Quick Takeaways
- This page summarizes Christopher B. Ehrlich's Form 4 filing for eFFECTOR Therapeutics, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 06 Oct 2022, 08:30.
Christopher B. Ehrlich - 04 Oct 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.
- Role
- Director
- Signature
- /s/ Michael Byrnes, Attorney-in-Fact for Christopher B. Ehrlich
- Issuer symbol
- N/A
- Transactions as of
- 04 Oct 2022
- Net transactions value
- +$197
- Form type
- 4
- Filing time
- 06 Oct 2022, 08:30:09 UTC
- Previous filing
- 27 Sep 2022
- Next filing
- 24 Jan 2023
- SEC
- View on sec.gov
Quoteable Key Fact
"Christopher B. Ehrlich filed Form 4 for eFFECTOR Therapeutics, Inc. on 06 Oct 2022."
What Changed
- Previous filing in this sequence was filed on 27 Sep 2022.
- Current net transaction value: +$197.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EFTR | Common Stock | Purchase | $197 | +346 | +0.99% | $0.5700 | 35,213 | 04 Oct 2022 | Direct | |
| holding | EFTR | Common Stock | 142,168 | 04 Oct 2022 | By Locust Walk Partners LLC | F1 | |||||
| holding | EFTR | Common Stock | 1,034 | 04 Oct 2022 | By Locust Walk Partners LLC | F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents shares held directly by the Sponsor, of which Locust Walk Partners LLC ("LWP") is a member. LWP has allocated these shares to the reporting person. |
| F2 | Represents shares held directly by the Sponsor, of which LWP is a member. LWP has allocated these shares to the reporting person's spouse. |